The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Public Health Scenario of Diabetes in India — Addressing the Challenges


Affiliations
1 Dr. Mohan’s Diabetes Specialities Centre & Madras Diabetes Research Foundation, Chennai, India
     

   Subscribe/Renew Journal


During the last two decades, non-communicable diseases (NCDs) have overtaken communicable diseases (CDs) as the major cause of morbidity and mortality in India. The Global Burden of Disease (GBD) Study India, showed that in the 1990s more than 50% of all deaths (and in some states upto 70%) were due to communicable diseases. This situation has completely changed, and now, in all the 31 states of India, non- communicable diseases form the major cause of death, ranging from 55–70% of all deaths in India(1). Among NCDs, the most rapid rise is seen in diabetes which is now reaching epidemic proportions in India(2). In the 1970s the prevalence of diabetes in urban areas of India was about 2% and in rural areas between 0.5 to 1%. Over the last 40 years, this has dramatically increased almost 10 fold(3,4). In metropolitan cities like Chennai and Delhi, the prevalence of diabetes is around 25% in those above 20 years of age. At age 55 and above almost 40% of the population has diabetes and another 35% have pre-diabetes which means that 75% of the population aged 55 years and above, in the metropolitan cities, have some form of dysglycemia(5).
Subscription Login to verify subscription
User
Notifications
Font Size


  • India State-level Disease Burden Initiative Collaborators. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet. 2017;390:2437 – 2460.

  • Tandon N, Anjana RM, Mohan V, Kaur T, Afshin A, Ong K, Mukhopadhyay S, Thomas N, Bhatia E, Krishnan A, Mathur P, Dhaliwal RS, et al. India State-Level Disease Burden Initiative Diabetes Collaborators*.The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Global Health. 2018. Sep 11. [Epub ahead of print].

  • Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, Datta M. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia. 2006;49:1175-8.

  • Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, Chia KS, Shaw JE, Zimmet PZ. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39:472-85.

  • Deepa M, Grace M, Binukumar B, Pradeepa R, Roopa S, Khan HM, Fatmi Z, Kadir MM, Naeem I, Ajay VS, Anjana RM, Ali MK, Prabhakaran D, Tandon N, Mohan V, Narayan KM; CARRS Surveillance Research Group. High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study. Diabetes Res Clin Pract. 2015;110:172-82.

  • Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A, John M, Luaia R, Reang T, Ningombam S, Jampa L, Budnah RO, Elangovan N, Subashini R, Venkatesan U, Unnikrishnan R, Das AK, Madhu SV, Ali MK, Pandey A, Dhaliwal RS, Kaur T, Swaminathan S, Mohan V; ICMR– INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5:585-596.

  • Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 Diabetes: Demystifying the Global Epidemic. Diabetes. 2017;66:1432-1442.

  • Amutha A, Datta M, Unnikrishnan R, Anjana RM, Mohan V. Clinical profile and complications of childhood- and adolescent-onset type 2 diabetes seen t a diabetes center in south India. Diabetes Technol Ther. 2012;14:497-504.

  • Amutha A, Anjana RM, Venkatesan U, Ranjani H, Unnikrishnan R, Narayan KMV, Mohan V, Ali MK. Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract. 2017;123:1-8.

  • Shrivastava U, Misra A, Gupta R, Viswanathan V. Socioeconomic factors relating to diabetes and its management in India. J Diabetes. 2016;8:12-23.

  • Ramachandran A, Ramachandran S, Snehalatha C, Augustine C, Murugesan N, Viswanathan V, Kapur A, Williams R. Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care. 2007;30:252-6.

  • Viswanathan V, Ranjan S. Diabetes - An ancient disease, epidemic & an economic burden for the present era. Indian J Med Res. 2016;143:389-91.

  • Sharma KM, Ranjani H, Zabetian A, Datta M, Deepa M, Moses CRA, Narayan KMV, Mohan V, Ali MK. Excess cost burden of diabetes in Southern India: a clinic-based, comparative cost-of-illness study. Glob Health Epidemiol Genom. 2016;1:e8.

  • Kapur A. Economic analysis of diabetes care. Indian J Med Res. 2007;125:473-82.

  • Kumar A, Nagpal J, Bhartia A. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey. J Assoc Physicians India. 2008;56:667-74.

  • Kumpatla S, Kothandan H, Tharkar S, Viswanathan V. The costs of treating long-term diabetic complications in a developing country: a study from India. J Assoc Physicians India. 2013;61:102-9.

  • Anjana RM, Pradeepa R, Das AK, Deepa M, Bhansali A, Joshi SR, Joshi PP, Dhandhania VK, Rao PV, Sudha V, Subashini R, Unnikrishnan R, Madhu SV, Kaur T, Mohan V, Shukla DK; ICMR– INDIAB Collaborative Study Group. Physical activity and inactivity patterns in India - results from the ICMR-INDIAB study (Phase-1) [ICMRINDIAB5]. Int J Behav Nutr Phys Act. 2014;11:26.

  • Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46:2328-33.

  • Unnikrishnan RI, Rema M, Pradeep R, Deepa M, Shanthirani, CS, Deepa R, Mohan V. Prevalence and risk factor of diabetic nephropathy in an urban south Indian population; The Chennai Urban Rural Epidemiology study (CURES-45). Diabetes Care. 2007;30:2019-2024. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008;25:407-12.

  • Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008; 25: 407- 412.

  • Premalatha G, Shanthi Rani CS, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected south Indian population – The Chennai Urban Population Study (CUPS). Diabetes Care, 2000;23:295-1300.

  • Mohan V, Deepa R, Rani SS, Premalatha G; Chennai Urban Population Study (CUPS No.5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001;38:682-7.

  • International Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017, Brussels, Belgium, 2017. Available at http://www.diabetesatlas.org/resources/2017-atlas. html/ [Accessed on 25th October 2018]

  • Weber MB, Ranjani H, Staimez LR, et al. The StepwiseApproach to DiabetesPrevention: Results from the D-CLIP Randomized Controlled Trial. Diabetes Care. 2016; 39:1760 – 1767.

  • Mohan V, Deepa M, Pradeepa R, Prathiba V, Datta M, Sethuraman R, Rakesh H, Sucharita Y, Webster P, Allender S, Kapur A, Anjana RM. Prevention of diabetes in rural India with a telemedicine intervention. J Diabetes Sci Technol. 2012;6:1355-64.

  • Mohan V, Radhika G, Sathya RM, Tamil SR, Ganesan A, Sudha V. Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59). Br J Nutr. 2009;102:1498-506.

  • Mohan V, Radhika G, Vijayalakshmi P, Sudha V. Can the diabetes/cardiovascular disease epidemic in India be explained, at least in part, by excess refined grain (rice) intake? Indian J Med Res. 2010;131:369-72.

  • Shobana S, Kokila A, Lakshmipriya N, Subhashini S, Ramya Bai M, Mohan V, Malleshi NG, Anjana RM, Henry CJ, Sudha V. Glycaemic index of three Indian rice varieties. Int J Food Sci Nutr. 2012;63:178-83.

  • Bhalla S, Unnikrishnan R, Srivastava R, Tandon N, Mohan V, Prabhakaran D. Innovation in capacity building of primary-care physicians in diabetes management in India: a new slant in medical education. Lancet Diabetes Endocrinol. 2016;4:200-202.

  • Mohan V, Williams OD, Chella S, Unnikrishnan R, Anjana RM, Vidyasagar S, Bhattacharya PK, Chaudhury N, Krishnan A, Garcia S, Lewis CE, Gross M, Pradeepa R. Clinical research training and capacity building for prevention and control of non-communicable diseases: A programme in India. Natl Med J India. 2017;30:340-344.

  • AYUSHMAN Bharat scheme. https://www.abnhpm.gov.in/[Accessed on 25th October 2018].


Abstract Views: 220

PDF Views: 0




  • Public Health Scenario of Diabetes in India — Addressing the Challenges

Abstract Views: 220  |  PDF Views: 0

Authors

V. Mohan
Dr. Mohan’s Diabetes Specialities Centre & Madras Diabetes Research Foundation, Chennai, India

Abstract


During the last two decades, non-communicable diseases (NCDs) have overtaken communicable diseases (CDs) as the major cause of morbidity and mortality in India. The Global Burden of Disease (GBD) Study India, showed that in the 1990s more than 50% of all deaths (and in some states upto 70%) were due to communicable diseases. This situation has completely changed, and now, in all the 31 states of India, non- communicable diseases form the major cause of death, ranging from 55–70% of all deaths in India(1). Among NCDs, the most rapid rise is seen in diabetes which is now reaching epidemic proportions in India(2). In the 1970s the prevalence of diabetes in urban areas of India was about 2% and in rural areas between 0.5 to 1%. Over the last 40 years, this has dramatically increased almost 10 fold(3,4). In metropolitan cities like Chennai and Delhi, the prevalence of diabetes is around 25% in those above 20 years of age. At age 55 and above almost 40% of the population has diabetes and another 35% have pre-diabetes which means that 75% of the population aged 55 years and above, in the metropolitan cities, have some form of dysglycemia(5).

References